Evidence map›Paper›PMID 32697872›Full record

ArticleCancer medicine2020

The artificial intelligence-assisted cytology diagnostic system in large-scale cervical cancer screening: A population-based cohort study of 0.7 million women.

Heling Bao, Xiaorong Sun, Yi Zhang, Baochuan Pang, Hua Li, Liang Zhou, Fengpin Wu, Dehua Cao, Jian Wang, Bojana Turic and 1 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in Cancer medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Review
  11. Artificial intelligence in the diagnosis and management of gynecologic cancer.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Heling BaoDepartment of Maternal and Child Health, School of Public Health, Peking University, Beijing, China.
Xiaorong SunLanding Cloud Medical Laboratory Co., Wuhan, China.
Yi ZhangElectronic and Information Engineering Department, Wenhua College, Wuhan, China.
Baochuan PangLanding Artificial Intelligence Center for Pathological Diagnosis, Wuhan University, Wuhan, China.
Hua LiLanding Cloud Medical Laboratory Co., Wuhan, China.
Liang ZhouLanding Cloud Medical Laboratory Co., Wuhan, China.
Fengpin WuLanding Cloud Medical Laboratory Co., Wuhan, China.
Dehua CaoLanding Cloud Medical Laboratory Co., Wuhan, China.
Jian WangLanding Cloud Medical Laboratory Co., Wuhan, China.
Bojana TuricLanding Cloud Medical Laboratory Co., Wuhan, China.ORCID 0000-0002-6624-4070
Linhong WangLanding Cloud Medical Laboratory Co., Wuhan, China.ORCID 0000-0002-9541-3654
Cloud Computing Center · CNPeking University · CNWuhan College · CNWuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdequate cytology is limited by insufficient cytologists in a large-scale cervical cancer screening. We aimed to develop an artificial intelligence (AI)-assisted cytology system in cervical cancer screening program.

methodsWe conducted a perspective cohort study within a population-based cervical cancer screening program for 0.7 million women, using a validated AI-assisted cytology system. For comparison, cytologists examined all slides classified by AI as abnormal and a randomly selected 10% of normal slides. Each woman with slides classified as abnormal by either AI-assisted or manual reading was diagnosed by colposcopy and biopsy. The outcomes were histologically confirmed cervical intraepithelial neoplasia grade 2 or worse (CIN2+).

resultsFinally, we recruited 703 103 women, of whom 98 549 were independently screened by AI and manual reading. The overall agreement rate between AI and manual reading was 94.7% (95% confidential interval [CI], 94.5%-94.8%), and kappa was 0.92 (0.91-0.92). The detection rates of CIN2+ increased with the severity of cytology abnormality performed by both AI and manual reading (P

conclusionsAI-assisted cytology system could exclude most of normal cytology, and improve sensitivity with clinically equivalent specificity for detection of CIN2+ compared with manual cytology reading. Overall, the results support AI-based cytology system for the primary cervical cancer screening in large-scale population.

Indexed as

CytodiagnosisDeep LearningDiagnosis, Computer-AssistedEarly Detection of CancerAdultAgedBiopsyChinaColposcopyFemaleHumansMiddle AgedNeoplasm GradingPredictive Value of TestsReproducibility of ResultsUterine Cervical Dysplasiaartificial intelligencecervical cancer screeningcytopathologypopulation-based study

Identifiers

PMID32697872
PMCPMC7520355
OpenAlexW3045487226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.